403 related articles for article (PubMed ID: 26421711)
1. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.
Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711
[TBL] [Abstract][Full Text] [Related]
2. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP
Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
[TBL] [Abstract][Full Text] [Related]
4. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial mass and DNA repair in breast cancer stem cells.
Pestell RG; Fatatis A; Jiao X
Oncotarget; 2015 Nov; 6(36):38442-3. PubMed ID: 26564961
[No Abstract] [Full Text] [Related]
6. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
8. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
[TBL] [Abstract][Full Text] [Related]
11. A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.
Ozsvari B; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Oct; 9(10):2098-2116. PubMed ID: 29080556
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial and ribosomal biogenesis are new hallmarks of stemness, oncometabolism and biomass accumulation in cancer: Mito-stemness and ribo-stemness features.
Peiris-Pagès M; Ozsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2019 Jul; 11(14):4801-4835. PubMed ID: 31311889
[TBL] [Abstract][Full Text] [Related]
13. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
[TBL] [Abstract][Full Text] [Related]
14. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
[TBL] [Abstract][Full Text] [Related]
15. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor.
Pfefferle AD; Darr DB; Calhoun BC; Mott KR; Rosen JM; Perou CM
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31213486
[TBL] [Abstract][Full Text] [Related]
16. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
[TBL] [Abstract][Full Text] [Related]
17. MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.
Teissedre B; Pinderhughes A; Incassati A; Hatsell SJ; Hiremath M; Cowin P
PLoS One; 2009; 4(2):e4537. PubMed ID: 19225568
[TBL] [Abstract][Full Text] [Related]
18. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
19. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
[TBL] [Abstract][Full Text] [Related]
20. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
Watanabe K; Fallahi M; Dai X
Oncogene; 2014 Jan; 33(5):632-42. PubMed ID: 23334328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]